Strides Pharma gets USFDA nod for generic Oxybutynin Chloride tablets
Drug firm Strides Pharma Science on Friday said its Singapore-based arm has received approval from the US health regulator for generic Oxybutynin Chlo18-12-2020
18-12-2020
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides receives USFDA approval for Oxybutynin Chloride Tablets18-12-2020
Buy Strides Pharma Science: target of Rs 980 : Sharekhan
Sharekhan is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 980 in its research report dated December 10, 2020.11-12-2020
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 02, 2020 for Pronomz Ventures LLP02-12-2020
Strides Pharma Science Ltd - 532531 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 01, 2020 for Pronomz Ventures LLP, Chayadeep Properties Pvt Ltd & Agnus Holdings Pvt Ltd01-12-2020
Strides Pharma Science Ltd - 532531 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 01, 2020 for Pronomz Ventures LLP & Arun Kumar Pillai01-12-2020
Strides Pharma on an upward journey
A break above 800 can take it to 850, then to 900 in the short to medium term29-11-2020
Strides Pharma Science Ltd - 532531 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to above, please find enclosed the disclosure of Related Party Transactions, on consolidated basis, for the half year ended September 30, 2020.26-11-2020
Strides gets USFDA nod for Prednisone tablets
Strides Pharma Science Limited has announced that its step-down, wholly-owned subsidiary Strides Pharma Global Pte Limited, Singapore, has received a23-11-2020
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides receives USFDA approval for Prednisone Tablets23-11-2020